Indian Study Finds CancerSpot May Improve Early Cancer Detection

Indian Study Finds CancerSpot May Improve Early Cancer Detection

A pan-Indian study published in the Proceedings of the National Academy of Sciences on 18 November 2026 found that CancerSpot, a blood test developed by Bengaluru-based Strand Life Sciences, detected 14 types of cancer. The non-invasive test uses DNA sequencing and artificial intelligence to identify cancer-related changes in cell-free DNA methylation patterns.

Study findings

The four-year study involved 1,480 participants across 43 hospitals, including 950 cancer patients and 450 healthy volunteers; the listed groups total 1,400. CancerSpot detected cancer in 72% of cases, with a 1.4% false-positive rate. An independent validation cohort recorded sensitivities of 79.3% for Stage I, 78.4% for Stage II, 78.4% for Stage III and 86.8% for Stage IV cancers. Researchers also found that higher levels of circulating cell-free DNA, including DNA from white blood cells, were associated with stronger cancer-related signals and improved detection sensitivity, even at the same cancer stage.

Test’s intended use and pricing

Strand Life Sciences CEO Ramesh Hariharan said in 2024 that the test aims to detect cancer before symptoms appear. The company plans to reduce its current price of about ₹22,000 to around ₹10,000 within two to three years.

Important Facts for Exams

  • Epigenetic regulation: DNA methylation can alter the activity of a DNA segment without changing its underlying sequence.
  • Cancer-associated silencing: In cancer, abnormal hypermethylation of promoter CpG islands can silence genes, with this silencing inherited by daughter cells after division.
  • Tissue-of-origin profiling: Cell-free DNA methylation profiles can preserve tissue-specific signatures, enabling some assays to infer the likely organ of origin of a cancer signal.
  • Blood-cell contribution: In healthy plasma, most cell-free DNA originates from haematopoietic cells, making blood-cell-derived fragments a substantial background in tumour detection.

Leave a Reply

Your email address will not be published. Required fields are marked *